Solomon Moshkevich, Chief Executive Officer of Natera, shared on LinkedIn:
“I’m excited to share that I have been named CEO of Natera.
As Natera’s third CEO in its 20-year history, it is an honor to lead this extraordinary team into our next chapter of expansion and innovation.
In Natera we are building an enduring healthcare company, transforming the practice of medicine by enabling earlier, more targeted interventions for those who need it, and by reducing unnecessary treatment for those who do not.
In the coming years, we will improve both treatment and prevention by generating more diagnostic insights from every blood and tissue specimen, applying novel technologies in entirely new patient populations, integrating more seamlessly at the point of care, and helping to save the global healthcare system billions of dollars.
Natera’s mission is to transform the management of disease worldwide.
It is a worthy mission and one I am proud to be on with our 6,500 employees.
To all of Natera’s employees, clients, research partners, investors, and most importantly to our patients: thank you for your trust.”
Other articles from Solomon Moshkevich on OncoDaily.